OREANDA-NEWS. February 10, 2012. The key for the development of domestic production of pharmaceutical products and promoting exports of domestic pharmaceutical products is creating regulatory framework that would meet international standards. This was stressed by the Minister of Health of Ukraine Oleksandr Anischenko during a briefing at the Cabinet of Ministers of Ukraine.

He noted that the Ministry of Health and the State Agency for medicines were made following steps in this direction. In particular, there were introduced national rules of an appropriate manufacturing practices (Good Manufacturing Practice, GMP), which fully correspond to European rules of Good Manufacturing Practice Medicinal Products for Human Use.

"Implementation of the GMP requirements in Ukraine and the entry of the regulatory body of Ukraine in the sphere of medicines to the PIC/S have allowed making "rules" in the pharmaceutical market transparent and understandable to the international community that have already given some positive results. Only in the first half of 2011, the volume of export of drugs from Ukraine amounted to 675 million UAH, having increased compared to the same period last year, by almost 20%," said Oleksandr Anishchenko.